Dr. Rupayan Kundu
Physician-Investigator Β· Moffitt Cancer Center
About Journey Research Publications Awards Leadership Contact
Abstract medical research background
Incoming Fellow β€” Moffitt Cancer Center / USF

Dr. Rupayan
Kundu, MD

Physician-Investigator in Hematology & Medical Oncology. Dedicated to advancing cancer epidemiology, hematologic malignancy care, and clinical trial accessibility.

0+
Peer-Reviewed Papers
#1
State Rank / 1M+
0/16
100% Mentee Match
5.0β˜…
Patients' Favorite
↓
Biography & Mission

The Physician Behind the Research

⭐ Healthgrades 5.0β˜… Physician
Dr. Rupayan Kundu, MD β€” Physician-Investigator
Dr. Rupayan Kundu, MD
Hematology & Medical Oncology Fellow
Moffitt Cancer Center Β· Cleveland Clinic Β· Mayo Clinic

From Rural Roots to World-Class Oncology

Born and raised in rural West Bengal, India, Dr. Rupayan Kundu overcame immense odds to become the first physician from his village. After securing Rank #1 statewide among over 1 million students β€” earning prestigious Chief Minister and Governor awards and having a sports complex named in his honor β€” he earned his MBBS at Nilratan Sircar Medical College in the top 10% of his class.

His clinical journey spans top U.S. institutions, from postdoctoral research at Mayo Clinic to Internal Medicine residency at Cleveland Clinic Foundation, culminating in his incoming Hematology & Medical Oncology fellowship at the NCI-designated Moffitt Cancer Center.

Investigation Across Malignancy & Epidemiology

Dr. Kundu’s research spans 23+ publications in leading journals including Blood, JCO Global Oncology, and Cancer Medicine. His work investigates 30-year global trends in early-onset GI cancers, high BMI-related cancer mortality across 204 nations, and determinants of clinical trial enrollment in hematologic malignancies.

Clinically, he focuses on acute leukemia, multiple myeloma, immune checkpoint inhibitor-induced toxicities, and early biomarker detection algorithms.

Empowering First-Generation Medical Trainees

Believing deeply in giving back, Dr. Kundu founded the 1st Generation Doctors Forum and co-founded Swastho Socheton (rural health literacy). He has personally mentored 16+ medical students and international graduates to a 100% residency match success rate.

He serves as a reviewer for PLOS ONE and Oxford Medical Case Reports, and sits on the editorial board for multiple medical science journals.

πŸ₯ Cleveland Clinic IM Resident ('23–'26)
πŸ”¬ Mayo Clinic Postdoc Fellow ('22–'23)
πŸŽ—οΈ Moffitt Hem/Onc Fellow ('26–'29)
πŸ… Sigma Xi Research Honor Society
Milestones

Academic & Clinical Journey

2026 β€” 2029

Fellowship β€” Hematology & Medical Oncology

Moffitt Cancer Center / University of South Florida, Tampa, FL

2023 β€” 2026

Residency β€” Internal Medicine

Cleveland Clinic Foundation, Cleveland, Ohio

2022 β€” 2023

Postdoctoral Research Fellow

Mayo Clinic, Rochester, Minnesota

2021 β€” 2022

Medical Officer β€” Internal Medicine

Arambagh Nursing Home & Hospital, West Bengal, India

2021

Clinical Clerkships

Mayo Clinic (Infectious Disease, Cardiology) Β· UNC Chapel Hill (Nephrology)

2015 β€” 2021

MBBS (MD Equivalent)

Nilratan Sircar Medical College, Kolkata β€” Top 10% of Class

2013 β€” 2015

Class XII Higher Secondary (Science)

WBCSHE β€” 94.0% (State Rank 23rd / 700,000+ examinees)

2013

πŸ† Rank #1 Statewide β€” Secondary Board Exam

WBBSE β€” 97.4% (Rank 1st / 1,000,000+) Β· Chief Minister & Governor Awards

Scientific Pillars

Areas of Investigation

🧬

Hematologic Malignancies

Acute myeloid leukemia (AML), multiple myeloma, Hodgkin & non-Hodgkin lymphoma, and adolescent/young adult (AYA) cancers.

🌍

Cancer Epidemiology

30-year global trends in early-onset GI cancers (colorectal, esophageal), and high BMI-attributable cancer mortality across 204 countries.

πŸ“Š

Clinical Trial Equity

Analyzing sociodemographic and geographic determinants of clinical trial enrollment success in oncology and systemic therapies.

πŸ”¬

Early Cancer Detection

Plasma methylated DNA markers, mutant KRAS, and CA 19-9 algorithms for early detection of pancreatic ductal adenocarcinoma (PDAC).

πŸ’Š

Immunotherapy Outcomes

Immune checkpoint inhibitor-induced colitis (imDC), infliximab dosing strategies, drug-induced liver injury, and toxicities.

πŸ₯

Quality Improvement

Care transition workflows between outpatient oncology and emergency departments. Lean Six Sigma-driven process optimizations.

Scholarly Work

Peer-Reviewed Publications (23+)

1

Temporal trends of colorectal cancer burden in India: A nationwide and state-level analysis

Cancer Medicine, 2026 Β· Peer-Reviewed Article
2

Global epidemiologic trends of early-onset cancers from 1990 to 2021 and projection to 2040

JCO Global Oncology, 2026 Β· Original Research
3

A global health crisis in young adults: 30-year trends in high BMI-related early-onset cancer mortality

Annals of Epidemiology, 2026 Β· Global Burden of Disease Analysis
4

Multiple myeloma in adolescents and young adults (AYA): global epidemiological trends, risk factors, and future projections (1990–2040)

Cancer Causes & Control, 2026 Β· Epidemiological Study
5

Semaglutide-induced hepatic injury: A rare case of drug-induced liver injury

Clinical Case Reports, 2025 Β· First-Author Case Report
6

State-wise disparities and temporal trends in acute myeloid leukemia (AML) in the United States

Leukemia & Lymphoma, 2025 Β· US Disparities Study
7

When the treatment becomes the problem: a case of paradoxical effects of IVIG

AIM Clinical Cases, 2025 Β· Clinical Case Study
8

Type A vs. Type B Lactic Acidosis in the Context of Undiagnosed B-Cell Lymphoma

BMJ Case Reports, 2025 Β· Hematologic Malignancy Presentation
9

How should I manage my patient with cancer who is experiencing diarrhea while on immunotherapy?

Cleveland Clinic Journal of Medicine, 2025 Β· Expert Review
10

Global incidence, mortality and risk factors of Hodgkin and non-Hodgkin lymphoma 1990–2021

Blood, 2024 Β· ASH Abstract / Oral Presentation
11

Epidemiological trends in incidence, death and associated risk factors of leukemia 1990–2021 and projection to 2040

Blood, 2024 Β· ASH Abstract
12

Epidemiological trends in incidence, death and associated risk factors of multiple myeloma 1990–2021 and projection to 2040

Blood, 2024 Β· ASH Abstract
13

Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder

Leukemia Research, 2024 Β· Review Article
14

A rare case of Philadelphia-positive (P210 BCR-ABL1) T-cell acute lymphoblastic leukemia/lymphoma

Leukemia Research Reports, 2024 Β· Novel Case Presentation
15

Predictors of pancreatic imaging abnormalities and concordance between EUS and MRI for pancreatic cancer screening in high-risk individuals

Gastroenterology, 2024 Β· Mayo Clinic Screening Study
16

Multilocular hepatic echinococcosis mimicking hepatic malignancy in a child: A diagnostic dilemma

IDCases, 2026 Β· Clinical Infectious Disease Case
17

Cutaneous leishmaniasis in a returned traveler

IDCases, 2022 Β· Case Study
18

Rare case of tacrolimus-induced acute pancreatitis in a liver transplant recipient

ACG Case Reports Journal, 2025 Β· Transplant Gastroenterology
19

Safety and performance of small bowel capsule endoscopy in patients with surgically altered gastrointestinal anatomy

Scandinavian Journal of Gastroenterology, 2026 Β· Endoscopic Safety
20

Determinants of childhood overweight and obesity among children 2–6 years of age in North Bengal

J Evolution of Medical and Dental Sciences, 2022 Β· Public Health Study
21

Assessment of pulmonary function tests in patients of hypothyroidism and effects of levothyroxine

J Evolution of Medical and Dental Sciences, 2018 Β· Physiology Study
22

Outcomes in cancer patients on prolonged Infliximab therapy for immune checkpoint inhibitor induced colitis

Submitted to JCO Oncology Practice, 2025 Β· Immunotherapy Toxicity
23

Cardiovascular events and mortality outcomes in cancer patients undergoing chimeric antigen receptor T-cell (CAR-T) therapy

In Preparation for Circulation / JACC, 2026 Β· Cardio-Oncology Study
Honors & Distinctions

Awards & Recognition

πŸ…

Patient Care Appreciation Award

2026 Β· Cleveland Clinic

Honored for exceptional clinical dedication, compassionate bedside care, and resident peer teaching.

🩸

ASH Abstract Achievement Award

2025 Β· American Society of Hematology

Merit-based research grant awarded for top-tier abstract presentation at the annual ASH meeting.

⭐

"Patients' Favorite" Designation

2025 Β· Healthgrades

Flawless 5.0/5.0-star patient satisfaction rating across all verified physician reviews.

πŸ”¬

Sigma Xi Honor Society

2024 Β· Elected Full Member

Inducted into the premier Scientific Research Honor Society boasting 200+ Nobel laureate members.

🏟️

"Rupayan Sports Complex"

2024 Β· State Honor

New multi-sport athletic complex at alma mater inaugurated and named in Dr. Kundu's honor.

πŸ›οΈ

Chief Minister & Governor Awards

2013 Β· West Bengal

State’s highest academic awards for securing Rank 1 statewide among 1,000,000+ examinees.

πŸ”‘

KVPY National Fellowship

2014 Β· Govt. of India

Prestigious fellowship awarded by DST, Govt. of India, for extraordinary scientific aptitude.

πŸ“

Lean Six Sigma Yellow Belt

2025 Β· Cleveland VA

Certified quality improvement leader executing process optimization for hospital workflows.

Service & Advocacy

Leadership & Mentorship

🧠

Peer-to-Peer Mental Health Counseling

Co-founded resident mental health network. Advanced to Phase 2 of Blackstone LaunchPad at USC Startup Competition.

Co-Founder Β· 2022–Present
πŸ‘¨β€βš•οΈ

1st Generation Doctors Forum

Leading 9 physician mentors supporting first-generation medical students with career roadmaps & residency guidance.

Founder & Chair Β· 2025–Present
🏘️

Swastho Socheton (Health Literacy)

Organized health education & screening camps across remote rural Indian villages in partnership with local centers.

Co-Founder Β· 2020–2025
πŸŽ“

Residency & USMLE Mentorship

Directly mentored 16+ medical students and IMGs. Achieved an absolute 100% residency match rate.

Mentor Β· 2023–Present
🚴

VeloSano: Bike to Cure Cancer

Team Co-Captain for Cleveland Clinic IM Grand Rounders, raising funds for cancer research through competitive cycling.

Co-Captain Β· 2024–Present
🌐

AAPI MSRF β€” Public Relations Chair

Chair of Public Relations for the American Association of Physicians of Indian Origin Medical Student Research Forum.

PR Chair Β· 2026–Present
Personal Pursuits

Life Outside the Lab

⚽

Football Captain

State champion (2013), intercollegiate champion (2018) against 14 medical colleges. Captained multiple squads.

πŸƒ

Competitive Sprinter

100m sprint PB: 11.7 seconds. Multi-time district & state sprinter. Active 5K marathon runner.

🏸

Badminton

2nd place in state-level singles tournament (2014) among 19 top competitors.

🌾

Family Farm & Agriculture

Actively works on his family farm in India cultivating rice, potatoes, and tomatoes. A grounding lifelong connection.

πŸ”οΈ

Trekking & Mountaineering

Himalayan high-altitude treks (Kuari Pass), Allegheny National Forest, and Hocking Hills explorer.

Get In Touch

Contact & Academic Network

Professional Reach

Open for collaborative research projects, oncology panels, mentorship inquiries, and academic invitations.

πŸ“
Moffitt Cancer Center / USF, Tampa, Florida
🌐
Mentoring 33,000+ Physicians & Medical Trainees

Send a Message